Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Altmann

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
Nature|November 10, 2021
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2Leo Swadling, Mariana O Diniz, Nathalie M Schmidt, et al.
Scientific Reports|September 27, 2022
Serum biomarkers associated with SARS-CoV-2 severityFabiani de Morais Batista, Marco Antonio Moreira Puga, Patricia Vieira da Silva, et al.
BMC Infectious Diseases|July 28, 2023
Multicenter study of the natural history and therapeutic responses of patients with chikungunya, focusing on acute and chronic musculoskeletal manifestations - a study protocol from the clinical and applied research in Chikungunya (REPLICK network)Giselle da Silva Duarte, Alexandra D Jones, Luciano Pamplona de Goes Cavalcanti, et al.
Eclinicalmedicine|October 16, 2023
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort studyZhigang Liu, James L Alexander, Kaixing Le, et al.
Science Immunology|December 28, 2020
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infectionCatherine J Reynolds, Leo Swadling, Joseph M Gibbons, et al.
The Journal of Infection|February 16, 2021
Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workersLetícia Adrielle Dos Santos, Pedro Germano de Góis Filho, Ana Maria Fantini Silva, et al.
Science (New York, N.Y.)|June 14, 2022
Immune boosting by B.1.1.529 <b>(</b>Omicron) depends on previous SARS-CoV-2 exposureCatherine J Reynolds, Corinna Pade, Joseph M Gibbons, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Nature|November 10, 2021
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2Leo Swadling, Mariana O Diniz, Nathalie M Schmidt, et al.
Scientific Reports|September 27, 2022
Serum biomarkers associated with SARS-CoV-2 severityFabiani de Morais Batista, Marco Antonio Moreira Puga, Patricia Vieira da Silva, et al.
BMC Infectious Diseases|July 28, 2023
Multicenter study of the natural history and therapeutic responses of patients with chikungunya, focusing on acute and chronic musculoskeletal manifestations - a study protocol from the clinical and applied research in Chikungunya (REPLICK network)Giselle da Silva Duarte, Alexandra D Jones, Luciano Pamplona de Goes Cavalcanti, et al.
Eclinicalmedicine|October 16, 2023
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort studyZhigang Liu, James L Alexander, Kaixing Le, et al.
Science Immunology|December 28, 2020
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infectionCatherine J Reynolds, Leo Swadling, Joseph M Gibbons, et al.
The Journal of Infection|February 16, 2021
Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workersLetícia Adrielle Dos Santos, Pedro Germano de Góis Filho, Ana Maria Fantini Silva, et al.
Science (New York, N.Y.)|June 14, 2022
Immune boosting by B.1.1.529 <b>(</b>Omicron) depends on previous SARS-CoV-2 exposureCatherine J Reynolds, Corinna Pade, Joseph M Gibbons, et al.
Pageof 15